- Hologic Announces Financial Results for Second Quarter of Fiscal 2024
- Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company
- Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
- Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
- Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
- Hologic to Unveil Groundbreaking AI Research at ECR 2024
- Hologic to Webcast Presentations at Upcoming Investor Conferences
More ▼
Key statistics
On Friday, Hologic Inc (HOLX:NSQ) closed at 75.14, -10.84% below its 52-week high of 84.28, set on May 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 75.64 |
---|---|
High | 75.99 |
Low | 75.01 |
Bid | 72.01 |
Offer | 80.00 |
Previous close | 75.75 |
Average volume | 1.46m |
---|---|
Shares outstanding | 233.38m |
Free float | 231.65m |
P/E (TTM) | 38.97 |
Market cap | 17.68bn USD |
EPS (TTM) | 1.94 USD |
Data delayed at least 15 minutes, as of May 10 2024 21:00 BST.
More ▼